Abstract
The childhood spinal muscular atrophy (SMA) is classified into three groups based on the age of onset and clinical course. The aim of this study was to define the correlation between genotype and phenotype in Iranian patients with SMA. Molecular analysis was carried out on two candidate genes of survival motor neuron one (SMN1), and neuronal apoptosis in- hibitory protein (NAIP) in 189 patients with SMA (130 patients with SMA type I, 32 patients with type II and 27 patients with type III) and the phenotypic features of SMA were compared with the deletion pattern of these genes. Polymerase chain reaction along with restriction fragment length polymorphism analysis were used to detect the deletion of exons 7 and 8 of SMN1 gene, as well as multiplex polymerase chain reaction for exon 5 of NAIP gene. Deletion in exon 7 was detected in 167 patients (88.4%); deletion in exon 8 was detected in 162 patients (85.7%) and deletion in exon 5 of NIAP gene was detected in 95 patients (50.3%). Deletion of exons 7 and/or 8 of SMN1 were detected in 90%, 84.4%, and 88.9% in patients with types I, II and III SMA, re- spectively. The prevalence rates of exon 5 deletion in NAIP gene was 66.9%, 12.5%, and 14.8% in types I, II and III SMA patients, respectively (P < 0.001). Combined homozygous deletion in both SMN1 and NAIP genes was found in 65.4% SMA type I, 12.5% SMA type II and 14.8% SMA type III (P < 0.001).There was a significant correlation between combined deletion of both SMN1 and NAIP genes and clinical subtypes of SMA patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.